onset of Parkinsonism. The present study suggests that Mninduced alteration of DNA methylation of PINK1-PARK2 may influence mitochondrial function and promote Parkinsonism. Our findings provide a basis to further explore and validate the epigenetic basis of Mn-induced neurotoxicity .
Introduction
Manganese (Mn) is naturally present in the environment and is a vital trace element required for proper functioning of cellular biochemical pathways. Although Mn is essential for human physiology, elevated exposure can elicit neurotoxic effects on the developing central nervous system (CNS) (Erikson et al. 2007; Tamm et al. 2008) . Miners and workers of ferroalloy, smelting and metallurgy industries are occupational populations exposed to manganese (Finkelstein and Jerrett 2007; Lucas et al. 2015) . Manganese-containing pesticide formulations such as maneb and paraquat are used in agriculture to treat various plant pathologies (Roede et al. 2011) . Methylcyclopentadienyl manganese tricarbonyl (MMT) used as a petrol anti-knock additive also releases Mn as a combustion product in the atmosphere (Crump 2000) . Recently high exposure to Mn has been reported to occur with use of psychoactive stimulants in recreational drugs (de Bie et al. 2007 ). The concentration of Mn in drinking water also was found to exceed the WHO regulatory standard (400 µg/L) (WHO 2006) . Significant levels of Mn have been detected in children hair samples and breast milk in populations residing in the vicinity of industrial steel plant (Sharma and Pervez 2005) . Therefore, the main paths of environmental exposure to Mn in the general population occur through intake of contaminated drinking water, dietary foods and inhalation of ambient air with elevated level of manganese (Roede et al. 2011; ATSDR 2012) .
High occupational and environmental exposure to Mn has been reported to cause manganism, a condition with neurological symptoms similar to those of idiopathic Parkinson's disease (Settivari et al. 2013) . Clinically, the symptom includes tremors, bradykinesia, rigidity, postural instability and facial muscle spasms (Kwakye et al. 2015) . The low chronic level of exposure to Mn for prolonged period has been found to be associated with elevated risk of developing Parkinson's disease (Gorell et al. 2004 ).
Parkinson's disease is characterized by the progressive loss of dopaminergic neurons in substantia nigra pars compacta (SNpc) with subsequent depletion of dopamine, impairing the execution of coordinated movements (Kanthasamy et al. 2012) . Recent evidence suggests that Mn deposition occurs in substantia nigra region and hence may be postulated to be associated with the etiology of Parkinson's disease (Park et al. 2007) .
Epigenetics entails the study of heritable changes in gene expression that occur independent of modifications to nucleotide sequences (Schnekenburger et al. 2007 ). Control of gene expression is essential for normal physiological functioning of cell, and the epigenetic machinery has an important role in regulating these processes. Epigenetic regulation includes of DNA methylation, histone modifications and miRNA expression. The involvement of epigenetic deregulation in the cause of various neurodegenerative disorders such as Parkinson's, Huntington Alzheimer and other mood disorders has been suggested (Migliore and Coppedè 2009) . Environmental toxicants that induce epigenetic alterations have been implicated in the susceptibility and progression of environmentally mediated chronic diseases (Baccarelli and Bollati 2009; Kanthasamy et al. 2012) .
The generation of oxidative stress through mitochondrial accumulation of Mn and subsequent mitochondrial respiratory dysfunction is thought to be primarily responsible for neurotoxic effects of manganese (McCubrey et al. 2006) . For example, Mn has been reported to cause apoptotic cell death via oxidative stress in the human neuroblastoma SH-SY5Y cell line (Stephenson et al. 2013) . Exposure to heavy metals such as As, Pb, Cd and Ni generates reactive oxygen species that may alter the level of DNA methylation in rat and other animal models (Martinez and Ha 2011) .
DNA methylation alterations occur primarily at CpG sites through addition of a methyl group to the 5′ position of cytosines. Around 70% of the CpGs sites are constitutively methylated in human genome, while unmethylated CpGs are generally located in CpG islands associated with promoter regions of genes (Martin and Zhang 2007) . Methylation modifications at CpG sites can induce conformational changes to chromatin and therefore modulate accessibility of gene promoter regions to the transcription machinery (Orphanides and Reinberg 2002) .
Human population is inevitably exposed to manganese in environmental and occupational settings. It is evident from epidemiological studies and available literature that populations exposed to low chronic levels of Mn have a propensity to develop idiopathic Parkinson's disease (Kim et al. 2002) . However, the hypothesis involving the potential role of epigenetic mechanisms in manganeseinduced neurotoxicity has not been explored (Tarale et al. 2016) .
In the present study, we investigated the impact of chronic Mn exposure on whole-genome DNA methylation levels and profiling of differentially methylated genes. We used the dopaminergic human neuroblastoma (SH-SY5Y) cell line as a model to explore the role of DNA methylation alterations induced by Mn and its possible association with Parkinson's disease. In support of our DNA methylation data, we also correlated differentially methylated regions with expression levels of Parkinson's disease-associated genes. The results of the present investigation provide insight how epigenetic mechanisms may promote manganese-induced idiopathic Parkinson's disease.
Materials and methods

Cell line
Human neuroblastoma (SH-SY5Y) cell line was procured from National Center for Cell Science (NCCS), Pune, India. Cells were grown in Ham's F-12 medium supplemented with 10% fetal bovine serum, 100 U/mL penicillin, 50 µg/mL streptomycin and 25 µg/mL Fungizone. Cells were maintained at 37 °C in a humidified atmosphere with 5% CO 2 .
Chronic Mn
2+ exposure SH-SY5Y cells were seeded in 25 mm 2 flask (5 × 10 5 cells/ ml) and grown up to 70% confluence level. After achieving the 70% confluence level, cells were exposed to 100 µM of Mn 2+ in the form of MnCl 2 (Sigma-Aldrich, USA). The dose of Mn 2+ for exposure in this study was selected based on the published research articles and preliminary studies (Bornhorst et al. 2013; Stephenson et al. 2013) . Chronic exposure of Mn 2+ was given for the period 30 days, and three controls and three exposed flasks were maintained during the period of exposure. Medium was subsequently changed at every third day and after each passage throughout the exposure period. Cells were treated with Mn 2+ after each passage after the cells get adhere to the flask.
Whole-genome (DNA) methylation sequencing and data processing
At the end of exposure period, cells were harvested for the whole-genome DNA methylation sequencing and analysis as follows.
Isolation of genomic DNA
SH-SY5Y cells were harvested and suspended in lysis buffer [500 µl of TNE buffer, 25 µl of 20% sodium dodecyl sulfate (SDS), 7.5 µl of proteinase K (20 mg/ml)]. Samples were then incubated at 37 °C for 3 h. After 3 h incubation, 250 µl of phenol:chloroform:isoamyl alcohol (25:24:1) was added to cell lysate and mixed well; further samples were kept for 30 min at room temperature. Later samples were centrifuged at 14000 g for 15 min. After centrifugation, aqueous layer was collected to new tubes and DNA was precipitated with 90% ethanol and 25 µl of 0.3 M sodium acetate. Samples were centrifuged at 14000 g for 10 min to pellet out the precipitated DNA. Precipitated DNA was washed with 70% ethanol and again re-centrifuged. Finally, DNA was air-dried and re-suspended in DNase-free water. Quantification of genomic DNA was carried out using ND8000 NanoDrop spectrophotometer.
Bisulfite conversion
EZ DNA Methylation Gold™ Kit (Zymo Research) was used for the bisulfite conversion of 20 µl (200 ng/µl) of genomic DNA. Twenty microliters of each DNA sample was mixed with 130 µl of CT conversion reagent and programmed at thermal cycler as: 98 °C for 10 min, 64 °C for 2.5 h, 4 °C for 20 h. After the incubation, 600 µl M binding buffer was added to tubes and transferred to Zymo spin IC column. Columns were centrifuged at 10000 g for 30 s. Following centrifugation, columns were washed with M-wash buffer. Later, 200 µl of M desulphonation buffer was added to columns and incubated at room temperature for 20 min followed by centrifugation at maximum speed. Columns were then washed with M buffer and bisulfite-converted genomic DNA was eluted with M-elution buffer.
Whole-genome bisulfite sequencing
Whole-genome bisulfite sequencing was carried out using EpiGnome™ Methyl-Seq Kit on IlluminaHiseq 2500. Hundred nanograms of bisulfite-converted genomic DNA samples was mixed with 2 µl DNA primer and incubated for 5 min at 90 °C. After the incubation, 4 µl of EpiGnome DNA synthesis premix, 0.5 µl of 100 mM DTT and 0.5 µl of EpiGnome polymerase were added to samples and programmed on thermal cycler (25 °C for 5 min, 42 °C for 30 min, 37 °C for 2 min). Later, 1.0 µl of exonuclease was added to each samples and reaction was programmed on thermal cycler (37 °C for 10 min, 95 °C for 3 min, 25 °C for 2 min). At the end of program, 8 µl of Terminal Tagging master mix (7.5 µl of EpiGnome™ Terminal Tagging premix and 0.5 µl DNA polymerase) was added to each sample tubes and programmed on thermal cycler (25 °C for 30 min, 95 °C for 3 min and hold at 4 °C). Prior proceeding DNA library preparation, DNA was purified using AMPure XP system to yield ditagged DNA. EpiGnome Index PCR Primer kit was used to generate whole-genome bisulfite library. To 22.5 µl of di-tagged DNA, 24 µl of FailSafe PCR premix E, 1.0 µl of EpiGnome forward primer, 1.0 µl of EpiGnome reverse primer and 0.5 µl of Failsafe PCR Enzyme were added and programmed on thermal cycler for 10 cycles as 95 °C for 30 s, 55 °C for 3 min, 68 °C and final extension at 68 °C for 7 min. Whole-genome bisulfite library was then purified by using AMPure XP system. Total yield of WGB library was quantified using Qubit fluorometer, and size distribution of WGB library was analyzed using 2100 bioanalyzer (Agilent). Whole-genome bisulfite sequencing (Paired End) of bisulfite library was carried out on IlluminaHiseq 2500 using Illumina SBS and Cluster kit.
Bismark alignment
Whole-genome bisulfite sequencing (WGBS) was carried out to generate the DNA methylation map of SH-SY5Y cell line chronically exposed to Mn (100 µM). Two biological replicates, each of control and exposed SH-SY5Y cell line, were sequenced. Bismark alignment in control and exposed samples mapped an average of 62% of reads the genome. The 90% of the sequenced data passed Q30 phred quality score. According to Bismark alignment, mapping efficiency within a range of 60-68% was considered as the best alignment percentage for reads of >80 base pairs of length. The whole-genome bisulfite sequencing (WGBS) data were submitted to National center for Biotechnology Information (NCBI) Sequence Read Archive (SRA) repository and can be accessed (SRP075314; SRP075316; SRP075243; SRP075313). The publically submitted whole-genome DNA methylation data may be further explored using other bioinformatics tools to obtain additional information in relevant to manganese neurotoxicity.
Methylation analysis and identification of differentially methylated genes
The base calling pipeline (HiSeq Control Software 2.2.38) was used for demultiplexing prior to the generation of fast-q-sequence files, i.e., by separating the libraries according to their indexes. Passed filter (PF) is a cluster that fulfills the default Illumina quality criteria; % of bases (PF) with a quality score greater or equal to 30 was used as a cutoff to remove sequences produced from clusters with low signal-to-noise ratio (e.g., overlapping DNA clusters). A 6-to 8-bp DNA sequence tag found in adaptor sequence to uniquely identify each library, used at demultiplexing step. This filtered reads are aligned to the human genome reference (hg19/GRCH37 assembly). Bismark tool (version 0.10.1) was used for the alignment of bisulfite-converted genome sequences. Each cytosine (C) present in raw reads was extracted from alignment output file (SAM file) using Bismark. The position of every cytosine (C) depending on cytosine (C) context (CpG, CHC and CHH) methylated cytosine (C) was labeled as "+" (forward read), while unmethylated cytosine (C) labeled as "−" (reversed read). Every methylated cytosine (C) was annotated against human reference genome using VariMAT tool. Each cytosine (C) was tracked to its original location in the genome based on its chromosome position to identify differentially methylated regions. Methylation difference between control and Mn 2+ -exposed cells was calculated by using DMAP (differential methylation analysis package for RRBS and WGBS data). We screened for differentially methylated genes between control and Mn-treated samples having methylation difference above 0.1 (hyper-or hypomethylation). The Database for Annotation, Visualization and Integrated Discovery (DAVID) version 6.7 (https://david.ncifcrf.gov/) was used for functional annotation clustering of differentially methylated genes.
Gene expression profiling for Parkinson's disease-associated genes
SH-SY5Y cells were harvested at the end of exposure period for the isolation of total RNA. Trizol reagent (Invitrogen) was used for the isolation of total RNA. Quantification of RNA was carried out using NanoDrop 8000 spectrophotometer. Two thousand nanograms of RNA was converted to cDNA using the RT 2 first strand kit (Qiagen, Germany) as per the manufacturer instructions. The Human Parkinson's Disease RT 2 Profiler PCR array (Qiagen, Germany) profiles the expression of 84 key genes directly or potentially involved in Parkinson's disease. Each RT 2 Profiler PCR array contains 12 controls that were used for the normalization of RT-PCR results. Applied Biosystems 7300 real-time PCR was used for the relative quantification, and RT-PCR was performed as per the manufacturer protocol. ΔΔCt method of relative quantification was used for the calculation of fold change and interpretation of control wells.
Results
Methylation profiling
We scanned the genome of Mn-treated and untreated SH-SY5Y cells for cytosine methylation by mapping methylated and unmethylated cytosines to a virtual, bisulfiteconverted human genome. Chronic exposure to manganese resulted in overall increase in the percentage of methylation density at CpG sites from 70.4 to 73.6% (Fig. 1a, b) . Methylation of cytosines has also been detected at nonCpG sites in neuronal DNA (Lister et al. 2013a, b) . We therefore examined our WGBS data sets for the presence of methylation events at CHG and CHH sites (H = A/C/T). In context of non-CpG sites, an increase in methylation level was detected at CHG sites, from 3.4 to 19.7% (Fig. 1c) . Similarly, at CHH sites methylation was markedly elevated, from 3.7 to 25.4% (Fig. 1d) .
The expression of genes is influenced by cytosine modifications. To map transcriptional start sites (TSS) and to identify genes associated with TSS regions on their original locations in chromosomes, we used VariMAT to annotate the observed cytosine methylation events. This gives the list of differentially methylated genes that are linked with altered state of CpG methylation.
Differentially methylated gene analysis
We examined whether a genome-wide trend for methylation of TSS could be detected. Methylation densities of CpG sites within 5 kilobase (kb) regions upstream and downstream of TSS were determined with 200 base pair (bp) genomic bins using our WGBS data. This analysis suggested a subtle trend toward methylated TSS and increased levels of cytosine modification downstream, in the gene bodies of the Mn-exposed samples (Supplementary figure S2 ). The WGBS data were further analyzed for identification of genomic sequences associated with a distinct CpG methylation status. Chromosome-wise analysis identified 24,868 differentially methylated genes. Genes from this list were further shortlisted based on the p value (<0.05) to obtain a list of around 10,213 differentially methylated genes at statistically significant level (Supplementary file 1). The list of genes was again screened, based on <0.1% methylation difference/change, yielding 6846 differentially methylated regions of genes. The heatmap showing the differential methylation status for genes with >0.1 methylation difference is given in supplementary figure S1. The Database for Annotation, Visualization and Integrated Discovery (DAVID) version 6.7 was used for functional annotation clustering of differentially methylated genes. The hypermethylated and hypomethylated genes were separately analyzed using the DAVID database for functional annotation and clustering. DAVID-based analysis shows that the hypermethylated genes are involved in metal ion binding (25%), cytoskeleton (16%), chromatin modification (12%), regulation of transcription (7%), apoptosis and iron binding (13%) (Fig. 2a) . The hypomethylated genes are involved in regulation of signal transduction (38%), transcription (15%), neuron differentiation and development (5%), synaptic transmission and MAPK signaling pathways (9%) (Fig. 2b) .The important hypermethylated genes regulating the synaptic transmission are PINK1, PARK2, SMAD7, VGF, DBH, GDNF, TH, GRIK3 and NGF. The genes responsible for regulating the apoptosis such as MGMT, CASP3, CARD14, MAPK8, MAP3K7, NGFR, YWHAZ were also found to be hypermethylated. The several inflammatory genes, including HRH1, IGF2, ITGB6, MAP2K3, YWHAZ, LYN and MASP1, were found to be hypomethylated. In summary, DAVID analysis reveals that manganese exposure alters the DNA methylation status of genes involved in the important biological pathways. The perturbation in the regulation of biological pathways via methylation alteration of associated genes may be responsible for the neurotoxic mechanism of manganese.
Correlation of differentially methylated genes with known genes in Parkinson's disease RT 2 Profiler array
The DNA methylation profiling approach identifies genes potentially involved in pathways related to Parkinson's disease. In order to correlate and validate the differentially methylated genes with their relative level of gene expression, we used the Human Parkinson's Disease RT 2 Profiler PCR array (Qiagen, Germany). From a total of 84 genes screened with this PCR array, we found that 34 genes had significantly diminished expression levels (p < 0.05) in the Mn-treated SH-SY5Y cells. To assess whether this set of down-regulated genes is enriched for certain functional pathways or networks, the DAVID database was used for annotation and clustering based on the gene ontology. The identified 34 genes were found to be involved in three biological pathways, including neuronal development and differentiation (17 genes), dopamine metabolic process (8 genes) and ubiquitin-mediated proteolysis (5 genes) (Fig. 3) . Important genes associated with these pathways are ATP2B2, DRD2, NRXN3, SLC25A4, SNCA, TH, VDAC, PARK2, PINK1, NSF, PAN2, STUB1 . These three pathways are known to play a role in the pathology of Parkinson's disease. The same pathways that we identified to be deregulated using the RT 2 expression profiler were also flagged by a DAVID analysis of the list of differentially methylated genes. The differentially methylated genes identified in the WGBS screen were compared to the list of 34 genes identified in the RT 2 PCR expression profiler array for human Parkinson's disease and additionally with genes that have been reported in the literature to be associated with Parkinson's disease. This type of comparison could indicate a probable connection between manganese-induced DNA methylation alteration and changes in expression of Parkinson's disease-associated genes. Based on this analysis, we identified 119 differentially methylated genes from our WGBS data set, which is shown in a heatmap (Fig. 4) .
Correlation of DNA methylation and gene expression in the present study identifies 10 genes in relevance to Parkinson's disease (APC, ATP2B2, CXXC1, DLK1, GBE1, NSF, PARK2, PINK1, TH and YWHAZ) (Fig. 5) . Among these 10 genes, TH, PARK2 and PINK1 are particularly recognized as important players in the etiology of Parkinson's disease as they have a significant role in the proteosomal degradation, protein kinase activity and dopamine biosynthesis Fig. 3 Gene ontology (GO) functional annotation cluster analysis was performed using DAVID database for differentially expressed genes identified in PCR array for Human Parkinson's Disease (Satake et al. 2009 ). Table 1 gives the list of 10 genes with their status in DNA methylation profile and RT 2 PCR gene expression analysis. The methylation alteration of these critical genes shows the probable association between manganese exposure and Parkinson's disease at an epigenetic level. The STRING database (Search Tool for the Retrieval of Interacting Genes/Proteins) is mainly devoted to documenting known and predicted functional protein-protein interactions. Our STRING analysis reveals a significant biological association between the genes as group with PPI (p value <0.0002) (Fig. 6) . The major biological process (GO) altered in connection to Parkinson's disease has been highlighted in Fig. 6 .
Discussion
Epigenetics has gained recognition as a biological mechanism that is associated with the manifestation of various human diseases. The interaction between gene and environment is thought to be, in part at least, mediated via epigenetic mechanisms. Epigenetic changes have already been implicated in certain cases of Parkinson's disease (Moyano et al. 2011) . There is growing evidence, suggesting a link between manganese exposure and Parkinson's disease (Racette et al. 2012) . However, there are limited studies that aimed to determine the connection between manganese exposure with deregulation in epigenetic mechanisms leading to Parkinson's disease (Yang et al. 2016) .
The human neuroblastoma cell line (SH-SY5Y) has been used as ex vivo cell model to investigate the neurotoxic mechanism of manganese (Li et al. 2010) . In the present study, we chronically exposed a neuroblastoma cell line to Mn 2+ (100 µM) for a period of 30 days, followed by WGBS and gene expression analysis for Parkinson's disease-associated genes. Hypermethylation of CpG sites within gene promoter regions generally correlates with repression of gene expression (Nan et al. 1998) . In contrast, non-CpG cytosine modifications have been detected in active genomic regions in human and mouse brain (Lister et al. 2013a, b; Guo et al. 2014) . In the present study, we observed an increase in non-CpG methylation, particularly at CHH sites (Fig. 1c, d ). The methyl CpG binding protein 2 (MECP2) plays an essential role in normal neuronal development (Chahrour et al. 2009 ) and appears to modulate transcription by interaction with both methylated CpG sites and methylated mCA sites (Lyst et al. 2013 ). The overall methylation increase at both CpG and non-CpG sites observed in the present study may be associated with an altered distribution of MECP2.
The WGBS data were further analyzed to identify specific genes with altered methylation. The list of significantly hypermethylated and hypomethylated genes was submitted to Database for Annotation, Visualization and Integrated Discovery (DAVID) for functional annotation and clustering (Dennis et al. 2003) . DAVID analysis indicates the involvement of these differentially methylated genes in multiple important biological pathways such as regulation of neuronal differentiation and development, synaptic transmission, signal transduction, inflammation and programmed cell death. Exposure to manganese has been reported to alter the DNA methylation status of various CpG loci during the neuro developmental process (Maccani et al. 2015) . The hypomethylation of inflammatory nitric oxide synthase gene (iNOS) was reported responsible for elevated signs of Parkinsonism among the Mn miners (Nielsen et al. 2014) . DAVID-based functional classification of genes in the present work also identifies the hypomethylation of inflammatory genes.
It is important to recognize there may not be a direct correlation between the DNA methylation status and expression profile of genes (Jones 2012) . Hence, it becomes important to integrate DNA methylation data with gene expression profiles. In the present study, combined analysis of gene expression in addition to the DNA methylation was carried out for a select number of genes. DAVID analysis identifies neuronal development, synaptic transmission and apoptosis as common pathways involved in Mn-induced Parkinsonism.
Clinically, Parkinson's disease is accompanied by motor dysfunction because of dopamine depletion occurring as a result of dopaminergic neuronal degeneration within the substantia nigra pars compacta (SNpc) (Kaidery et al. 2013) . Five genetic loci, including α-synuclein, parkin, PINK1, DJ-1 and LRRK2, are the most extensively studied and considered as critical risk factors for the onset (Rochet et al. 2012) . In the present study, activity of two genetic loci, parkin and PINK1, was found to be altered via hypermethylation upon manganese exposure. Tyrosine hydroxylase (TH) has an important role in dopamine biosynthesis. Mn exposure has been found to alter the activity of TH, both in dopaminergic neuronal cells and a zebrafish model of manganism (Zhang et al. 2011; Bakthavatsalam et al. 2014) . The result of the present investigation suggests that cytosine methylation plays a role in modulating TH gene activity and may contribute to diminished expression levels, which is in agreement with previous studies on Mn neurotoxicity (Bakthavatsalam et al. 2014) . However, our results require further validation and testing in other animal models.
Parkin/PARK2 is an autosomal recessive gene, and mutations in one of the alleles have been shown to cause the clinical features of Parkinsonism and as risk factor for early onset of Parkinson's disease (EOPD) (Periquet et al. 2003; Padmaja et al. 2012 ). The present study suggests that hypermethylation of PARK2 with subsequent reduction in gene expression may be another molecular mechanism that potentiates Mn toxicity via loss of control over Divalent Metal Transporter (DMT1)-mediated Mn transport (Roth and Garrick 2003; Higashi et al. 2004) .
PINK1 is a serine/threonine kinase with neuroprotective function that localizes to mitochondria (Petit et al. 2005; Silvestri et al. 2005) . We found PINK1 expression to be decreased in the present study, presumably through hypermethylation of the gene. Perturbation in PINK1 function through mutation has been reported to cause impairment of mitochondrial function, synaptic transmission and elevated sensitivity to oxidative stress (Kitada et al. 2007; Gautier et al. 2008 ). PINK1 has also been found to interact with polycomb histone-methylation modulator (EED/WAIT1) and regulate gene expression during SH-SY5Y differentiation (Berthier et al. 2013) .
PARK2 and PINK1 have been identified as key genes responsible for early onset of Parkinsonism via loss of mitochondrial quality control (Matsuda and Tanaka 2015) . Mitochondrial quality control is an essential function of healthy neurons ensuring cell survival, while dysfunction of complex I has been reported to induce Parkinsonism and sporadic Parkinson's disease (Schapira 2008) . Parkin/PARK2 is selectively targeted to depolarized mitochondria to facilitate the removal of damaged mitochondria through ubiquitination of outer mitochondrial substrate (Narendra et al. 2010) . PINK1 kinase activity is responsible for both activation and recruitment of PARK2 to mitochondrial membrane (Pickrell and Youle 2014) . Initially, PINK1 phosphorylate ubiquitin on depolarized mitochondria that function as an activator of PARK2 activity through repression of auto-inhibiting activity of PARK2 (Trempe et al. 2013) . The subsequent events of ubiquitin-phosphorylation act as a signal for PINK1-/PARK2-mediated mitophagy-based removal of depolarized mitochondria (Lin et al. 2015) . The findings suggest that PINK1/PARK2 together have a vital role in regulating mitochondrial quality control and therefore appear to prevent the onset of Parkinsonism (Narendra et al. 2012; Pickrell and Youle 2014) . DNA methylation studies in manganese-exposed mouse model recently reported alteration to several mitochondrial genes (Yang et al. 2016) . Epigenetic down-regulation of both PINK1/ PARK2 through hypermethylation in the present study supports the previous findings and supports the concept that mitochondrial dysfunction might be responsible for Mn-induced Parkinsonism. This is one among the few studies to reveal manganese-induced alterations in DNA methylation. The results indicate the influence of chronic manganese exposure on epigenetic de-regulation of Parkinson's disease-associated pathways. Our data along with those communicated by Yang and colleagues (Yang et al. 2016 ) signify the importance of considering the role of epigenetic mechanisms in Mn-induced neurotoxic effects. These results require validation and replication in other animal models of Parkinson's disease.
Conclusion
The study shows that chronic manganese exposure on dopaminergic human neuroblastoma cells (SH-SY5Y) induces global alteration to DNA methylation levels of genes involved in biological pathways, including neuronal development and differentiation, synaptic transmission, signal transduction and inflammation. Mitochondrial dysfunction is known to be involved in Parkinsonism, and Mn has also been shown to alter mitochondrial function. The present study suggests an epigenetic alteration of PINK1/ PARK2, which might contribute to the Mn-mediated mitochondrial dysfunction and probably in the etiology of Parkinson's disease. A better understanding of Mn-induced neurotoxicity and an altered epigenetic landscape that comes along with Mn exposure could lead to the identification of new prognostic and therapeutic epigenetic targets.
